8-K - Zura Bio Ltd - 5.02 / 9.01
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001104659-26-047784
Filing Date: 2026-04-23
Accepted: 2026-04-23 16:50:58
Documents: 12
Period of Report: 2026-04-20
Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Zura Bio Ltd (Filer) CIK : 0001855644 (see all company filings) EIN. : 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 26889380 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)
1 | FORM 8-K | tm2612540d1_8k.htm iXBRL | 8-K
2 | EXHIBIT 10.1 | tm2612540d1_ex10-1.htm | EX-10.1
3 | XBRL TAXONOMY EXTENSION SCHEMA | zura-20260420.xsd | EX-101.SCH
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | zura-20260420_lab.xml | EX-101.LAB